Treatment Strategy for Long COVID Based on Traditional Chinese Medicine.

Juntendo medical journal Pub Date : 2025-04-03 eCollection Date: 2025-01-01 DOI:10.14789/ejmj.JMJ24-0041-P
Mahiko Nagase, Yuu Takeshita, Kiyohide Tomooka
{"title":"Treatment Strategy for Long COVID Based on Traditional Chinese Medicine.","authors":"Mahiko Nagase, Yuu Takeshita, Kiyohide Tomooka","doi":"10.14789/ejmj.JMJ24-0041-P","DOIUrl":null,"url":null,"abstract":"<p><p>Post-acute COVID-19 conditions, commonly known as 'long COVID', occur in individuals with a history of probable or confirmed severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection, typically 3 months from the onset of COVID-19 with symptoms, lasting for at least 2 months, that cannot be explained by any alternative diagnoses. Although most symptoms improve over time, some patients experience significant limitations in their social lives. Under such circumstances, complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. There are a wide variety of CAM interventions, such as traditional Japanese medicine (Kampo medicine) and traditional Chinese medicine (TCM). In this study, we compared three studies using Kampo medicine with those using TCM and concluded that Kampo medicine, which is often practiced in Japan due to its historical background, may have some limitations in managing the diverse symptoms of long COVID because the symptoms of long COVID vary widely. Therefore, we propose that medical examinations based on TCM should also be considered as an alternative treatment strategy for patients with long COVID.</p>","PeriodicalId":520470,"journal":{"name":"Juntendo medical journal","volume":"71 2","pages":"102-105"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086455/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Juntendo medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14789/ejmj.JMJ24-0041-P","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Post-acute COVID-19 conditions, commonly known as 'long COVID', occur in individuals with a history of probable or confirmed severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) infection, typically 3 months from the onset of COVID-19 with symptoms, lasting for at least 2 months, that cannot be explained by any alternative diagnoses. Although most symptoms improve over time, some patients experience significant limitations in their social lives. Under such circumstances, complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. There are a wide variety of CAM interventions, such as traditional Japanese medicine (Kampo medicine) and traditional Chinese medicine (TCM). In this study, we compared three studies using Kampo medicine with those using TCM and concluded that Kampo medicine, which is often practiced in Japan due to its historical background, may have some limitations in managing the diverse symptoms of long COVID because the symptoms of long COVID vary widely. Therefore, we propose that medical examinations based on TCM should also be considered as an alternative treatment strategy for patients with long COVID.

基于中医的长期COVID治疗策略。
COVID-19急性后病症,通常被称为“长COVID”,发生在可能或确诊的严重急性呼吸综合征冠状病毒2 (SARS - CoV-2)感染史的个体中,通常在COVID-19发病后3个月出现症状,持续至少2个月,无法用任何替代诊断来解释。虽然大多数症状会随着时间的推移而改善,但有些患者的社交生活受到严重限制。在这种情况下,补充和替代医学(CAM)干预措施作为治疗长期COVID症状的可能方法越来越受欢迎。有各种各样的CAM干预措施,如传统日本医学(汉布医学)和传统中医(TCM)。在本研究中,我们比较了三项使用汉方医学和使用中医的研究,并得出结论,由于日本的历史背景,汉方医学在治疗长冠状病毒的多种症状方面可能存在一定的局限性,因为长冠状病毒的症状差异很大。因此,我们建议将中医医学检查作为长期COVID患者的替代治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信